NCT06646211 2024-10-17High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)Sun Yat-sen UniversityPhase 2 Not yet recruiting30 enrolled
NCT06427213 2024-05-23This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell LymphomaHenan Cancer HospitalPhase 2 Not yet recruiting41 enrolled